Ontology type: schema:ScholarlyArticle Open Access: True
2022-04-14
AUTHORSThomas J. Green, Lauren E. Walker, Richard M. Turner
ABSTRACTPurposeTherapeutic drug monitoring (TDM) is widely recognised as a key attribute of clinical pharmacologists; yet, the extent to which physicians undertaking postgraduate training in clinical pharmacology (hereafter trainees) are involved in TDM is poorly characterised. Our own experience suggests wide variation in trainee exposure to TDM.MethodWe performed a Europe-wide cross-sectional internet-based survey of trainees to determine the nature and extent of trainee involvement in TDM.ResultsThere were 43 responses from eight countries analysed. Of the 21 respondents from the UK, all were also training in general internal medicine (GIM), while all of the respondents who were solely training in clinical pharmacology were from outside the UK. Overall, 86.0% of respondents reported access to drug monitoring for clinical care at their affiliated institution, of which 81.0% were personally involved in TDM in some capacity. On average, trainees reported that drug monitoring was available for 16 of the 33 (48%) of the drug/drug classes surveyed. UK-based respondents were involved in requesting drug-level investigations and interpreting the results for patients under their care in 76.2% and 85.7% of cases, respectively, while non-UK respondents supported other healthcare professionals to interpret results in 45.4% of cases. Trainees felt TDM training was generally either insufficient or very inadequate.ConclusionWhile access to TDM is relatively available at institutions where trainees are based, the role of trainees is variable and affected by a variety of factors including country and training programme. Universally, trainees feel they need more education in TDM. More... »
PAGES1-9
http://scigraph.springernature.com/pub.10.1007/s00228-022-03316-z
DOIhttp://dx.doi.org/10.1007/s00228-022-03316-z
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1147115724
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/35426080
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Public Health and Health Services",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK",
"id": "http://www.grid.ac/institutes/grid.10025.36",
"name": [
"Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK"
],
"type": "Organization"
},
"familyName": "Green",
"givenName": "Thomas J.",
"type": "Person"
},
{
"affiliation": {
"alternateName": "The Wolfson Centre for Personalised Medicine, University of Liverpool, Liverpool, UK",
"id": "http://www.grid.ac/institutes/grid.10025.36",
"name": [
"The Wolfson Centre for Personalised Medicine, University of Liverpool, Liverpool, UK"
],
"type": "Organization"
},
"familyName": "Walker",
"givenName": "Lauren E.",
"type": "Person"
},
{
"affiliation": {
"alternateName": "The Wolfson Centre for Personalised Medicine, University of Liverpool, Liverpool, UK",
"id": "http://www.grid.ac/institutes/grid.10025.36",
"name": [
"The Wolfson Centre for Personalised Medicine, University of Liverpool, Liverpool, UK"
],
"type": "Organization"
},
"familyName": "Turner",
"givenName": "Richard M.",
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1007/s00228-014-1787-6",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1024954211",
"https://doi.org/10.1007/s00228-014-1787-6"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00228-013-1519-3",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1018931497",
"https://doi.org/10.1007/s00228-013-1519-3"
],
"type": "CreativeWork"
}
],
"datePublished": "2022-04-14",
"datePublishedReg": "2022-04-14",
"description": "PurposeTherapeutic drug monitoring (TDM) is widely recognised as a key attribute of clinical pharmacologists; yet, the extent to which physicians undertaking postgraduate training in clinical pharmacology (hereafter trainees) are involved in TDM is poorly characterised. Our own experience suggests wide variation in trainee exposure to TDM.MethodWe performed a Europe-wide cross-sectional internet-based survey of trainees to determine the nature and extent of trainee involvement in TDM.ResultsThere were 43 responses from eight countries analysed. Of the 21 respondents from the UK, all were also training in general internal medicine (GIM), while all of the respondents who were solely training in clinical pharmacology were from outside the UK. Overall, 86.0% of respondents reported access to drug monitoring for clinical care at their affiliated institution, of which 81.0% were personally involved in TDM in some capacity. On average, trainees reported that drug monitoring was available for 16 of the 33 (48%) of the drug/drug classes surveyed. UK-based respondents were involved in requesting drug-level investigations and interpreting the results for patients under their care in 76.2% and 85.7% of cases, respectively, while non-UK respondents supported other healthcare professionals to interpret results in 45.4% of cases. Trainees felt TDM training was generally either insufficient or very inadequate.ConclusionWhile access to TDM is relatively available at institutions where trainees are based, the role of trainees is variable and affected by a variety of factors including country and training programme. Universally, trainees feel they need more education in TDM.",
"genre": "article",
"id": "sg:pub.10.1007/s00228-022-03316-z",
"inLanguage": "en",
"isAccessibleForFree": true,
"isPartOf": [
{
"id": "sg:journal.1054337",
"issn": [
"0031-6970",
"1432-1041"
],
"name": "European Journal of Clinical Pharmacology",
"publisher": "Springer Nature",
"type": "Periodical"
}
],
"keywords": [
"clinical pharmacology",
"general internal medicine",
"drug monitoring",
"European cross-sectional survey",
"drugs/drug classes",
"cross-sectional Internet-based survey",
"drug concentration monitoring",
"cross-sectional survey",
"PurposeTherapeutic drug monitoring",
"drug classes",
"clinical pharmacologists",
"Internet-based survey",
"clinical care",
"involved doctors",
"trainee involvement",
"internal medicine",
"trainee exposure",
"healthcare professionals",
"pharmacology",
"more education",
"care",
"concentration monitoring",
"postgraduate training",
"variety of factors",
"training program",
"role of trainees",
"trainees",
"wide variation",
"patients",
"respondents",
"ResultsThere",
"MethodWe",
"TDM",
"pharmacologists",
"doctors",
"cases",
"exposure",
"involvement",
"monitoring",
"medicine",
"training",
"UK",
"own experience",
"survey",
"professionals",
"response",
"extent",
"factors",
"access",
"institutions",
"role",
"countries",
"experience",
"results",
"program",
"education",
"investigation",
"variety",
"capacity",
"key attributes",
"variation",
"class",
"nature",
"attributes"
],
"name": "A European cross-sectional survey to investigate how involved doctors training in clinical pharmacology are in drug concentration monitoring",
"pagination": "1-9",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1147115724"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s00228-022-03316-z"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"35426080"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s00228-022-03316-z",
"https://app.dimensions.ai/details/publication/pub.1147115724"
],
"sdDataset": "articles",
"sdDatePublished": "2022-06-01T22:24",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220601/entities/gbq_results/article/article_937.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1007/s00228-022-03316-z"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00228-022-03316-z'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00228-022-03316-z'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00228-022-03316-z'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00228-022-03316-z'
This table displays all metadata directly associated to this object as RDF triples.
141 TRIPLES
22 PREDICATES
90 URIs
80 LITERALS
5 BLANK NODES
Subject | Predicate | Object | |
---|---|---|---|
1 | sg:pub.10.1007/s00228-022-03316-z | schema:about | anzsrc-for:11 |
2 | ″ | ″ | anzsrc-for:1117 |
3 | ″ | schema:author | N2b46ee6083214826bd90f044c2498cb5 |
4 | ″ | schema:citation | sg:pub.10.1007/s00228-013-1519-3 |
5 | ″ | ″ | sg:pub.10.1007/s00228-014-1787-6 |
6 | ″ | schema:datePublished | 2022-04-14 |
7 | ″ | schema:datePublishedReg | 2022-04-14 |
8 | ″ | schema:description | PurposeTherapeutic drug monitoring (TDM) is widely recognised as a key attribute of clinical pharmacologists; yet, the extent to which physicians undertaking postgraduate training in clinical pharmacology (hereafter trainees) are involved in TDM is poorly characterised. Our own experience suggests wide variation in trainee exposure to TDM.MethodWe performed a Europe-wide cross-sectional internet-based survey of trainees to determine the nature and extent of trainee involvement in TDM.ResultsThere were 43 responses from eight countries analysed. Of the 21 respondents from the UK, all were also training in general internal medicine (GIM), while all of the respondents who were solely training in clinical pharmacology were from outside the UK. Overall, 86.0% of respondents reported access to drug monitoring for clinical care at their affiliated institution, of which 81.0% were personally involved in TDM in some capacity. On average, trainees reported that drug monitoring was available for 16 of the 33 (48%) of the drug/drug classes surveyed. UK-based respondents were involved in requesting drug-level investigations and interpreting the results for patients under their care in 76.2% and 85.7% of cases, respectively, while non-UK respondents supported other healthcare professionals to interpret results in 45.4% of cases. Trainees felt TDM training was generally either insufficient or very inadequate.ConclusionWhile access to TDM is relatively available at institutions where trainees are based, the role of trainees is variable and affected by a variety of factors including country and training programme. Universally, trainees feel they need more education in TDM. |
9 | ″ | schema:genre | article |
10 | ″ | schema:inLanguage | en |
11 | ″ | schema:isAccessibleForFree | true |
12 | ″ | schema:isPartOf | sg:journal.1054337 |
13 | ″ | schema:keywords | European cross-sectional survey |
14 | ″ | ″ | Internet-based survey |
15 | ″ | ″ | MethodWe |
16 | ″ | ″ | PurposeTherapeutic drug monitoring |
17 | ″ | ″ | ResultsThere |
18 | ″ | ″ | TDM |
19 | ″ | ″ | UK |
20 | ″ | ″ | access |
21 | ″ | ″ | attributes |
22 | ″ | ″ | capacity |
23 | ″ | ″ | care |
24 | ″ | ″ | cases |
25 | ″ | ″ | class |
26 | ″ | ″ | clinical care |
27 | ″ | ″ | clinical pharmacologists |
28 | ″ | ″ | clinical pharmacology |
29 | ″ | ″ | concentration monitoring |
30 | ″ | ″ | countries |
31 | ″ | ″ | cross-sectional Internet-based survey |
32 | ″ | ″ | cross-sectional survey |
33 | ″ | ″ | doctors |
34 | ″ | ″ | drug classes |
35 | ″ | ″ | drug concentration monitoring |
36 | ″ | ″ | drug monitoring |
37 | ″ | ″ | drugs/drug classes |
38 | ″ | ″ | education |
39 | ″ | ″ | experience |
40 | ″ | ″ | exposure |
41 | ″ | ″ | extent |
42 | ″ | ″ | factors |
43 | ″ | ″ | general internal medicine |
44 | ″ | ″ | healthcare professionals |
45 | ″ | ″ | institutions |
46 | ″ | ″ | internal medicine |
47 | ″ | ″ | investigation |
48 | ″ | ″ | involved doctors |
49 | ″ | ″ | involvement |
50 | ″ | ″ | key attributes |
51 | ″ | ″ | medicine |
52 | ″ | ″ | monitoring |
53 | ″ | ″ | more education |
54 | ″ | ″ | nature |
55 | ″ | ″ | own experience |
56 | ″ | ″ | patients |
57 | ″ | ″ | pharmacologists |
58 | ″ | ″ | pharmacology |
59 | ″ | ″ | postgraduate training |
60 | ″ | ″ | professionals |
61 | ″ | ″ | program |
62 | ″ | ″ | respondents |
63 | ″ | ″ | response |
64 | ″ | ″ | results |
65 | ″ | ″ | role |
66 | ″ | ″ | role of trainees |
67 | ″ | ″ | survey |
68 | ″ | ″ | trainee exposure |
69 | ″ | ″ | trainee involvement |
70 | ″ | ″ | trainees |
71 | ″ | ″ | training |
72 | ″ | ″ | training program |
73 | ″ | ″ | variation |
74 | ″ | ″ | variety |
75 | ″ | ″ | variety of factors |
76 | ″ | ″ | wide variation |
77 | ″ | schema:name | A European cross-sectional survey to investigate how involved doctors training in clinical pharmacology are in drug concentration monitoring |
78 | ″ | schema:pagination | 1-9 |
79 | ″ | schema:productId | N6401d6a3a70e458e9f0c9d78fd18577f |
80 | ″ | ″ | Na208b2fc28c6431b8855cec67e4809a4 |
81 | ″ | ″ | Nd9a6e85abd394c91b4057c3f601500ba |
82 | ″ | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1147115724 |
83 | ″ | ″ | https://doi.org/10.1007/s00228-022-03316-z |
84 | ″ | schema:sdDatePublished | 2022-06-01T22:24 |
85 | ″ | schema:sdLicense | https://scigraph.springernature.com/explorer/license/ |
86 | ″ | schema:sdPublisher | Nf7713fb196e04288b894ac15367dc5f5 |
87 | ″ | schema:url | https://doi.org/10.1007/s00228-022-03316-z |
88 | ″ | sgo:license | sg:explorer/license/ |
89 | ″ | sgo:sdDataset | articles |
90 | ″ | rdf:type | schema:ScholarlyArticle |
91 | N05ec0c2afd3c4ab098b682de91c73e12 | schema:affiliation | grid-institutes:grid.10025.36 |
92 | ″ | schema:familyName | Green |
93 | ″ | schema:givenName | Thomas J. |
94 | ″ | rdf:type | schema:Person |
95 | N2b46ee6083214826bd90f044c2498cb5 | rdf:first | N05ec0c2afd3c4ab098b682de91c73e12 |
96 | ″ | rdf:rest | N3821179296ec4920a47a790fd8667091 |
97 | N3821179296ec4920a47a790fd8667091 | rdf:first | Ndf4bfa6c5c4846578286512b13204399 |
98 | ″ | rdf:rest | Na52f15acbdb542fe95b3f7aad10d5dbe |
99 | N6401d6a3a70e458e9f0c9d78fd18577f | schema:name | dimensions_id |
100 | ″ | schema:value | pub.1147115724 |
101 | ″ | rdf:type | schema:PropertyValue |
102 | Na208b2fc28c6431b8855cec67e4809a4 | schema:name | pubmed_id |
103 | ″ | schema:value | 35426080 |
104 | ″ | rdf:type | schema:PropertyValue |
105 | Na52f15acbdb542fe95b3f7aad10d5dbe | rdf:first | Nb482729a642e4940903890b1941966e5 |
106 | ″ | rdf:rest | rdf:nil |
107 | Nb482729a642e4940903890b1941966e5 | schema:affiliation | grid-institutes:grid.10025.36 |
108 | ″ | schema:familyName | Turner |
109 | ″ | schema:givenName | Richard M. |
110 | ″ | rdf:type | schema:Person |
111 | Nd9a6e85abd394c91b4057c3f601500ba | schema:name | doi |
112 | ″ | schema:value | 10.1007/s00228-022-03316-z |
113 | ″ | rdf:type | schema:PropertyValue |
114 | Ndf4bfa6c5c4846578286512b13204399 | schema:affiliation | grid-institutes:grid.10025.36 |
115 | ″ | schema:familyName | Walker |
116 | ″ | schema:givenName | Lauren E. |
117 | ″ | rdf:type | schema:Person |
118 | Nf7713fb196e04288b894ac15367dc5f5 | schema:name | Springer Nature - SN SciGraph project |
119 | ″ | rdf:type | schema:Organization |
120 | anzsrc-for:11 | schema:inDefinedTermSet | anzsrc-for: |
121 | ″ | schema:name | Medical and Health Sciences |
122 | ″ | rdf:type | schema:DefinedTerm |
123 | anzsrc-for:1117 | schema:inDefinedTermSet | anzsrc-for: |
124 | ″ | schema:name | Public Health and Health Services |
125 | ″ | rdf:type | schema:DefinedTerm |
126 | sg:journal.1054337 | schema:issn | 0031-6970 |
127 | ″ | ″ | 1432-1041 |
128 | ″ | schema:name | European Journal of Clinical Pharmacology |
129 | ″ | schema:publisher | Springer Nature |
130 | ″ | rdf:type | schema:Periodical |
131 | sg:pub.10.1007/s00228-013-1519-3 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1018931497 |
132 | ″ | ″ | https://doi.org/10.1007/s00228-013-1519-3 |
133 | ″ | rdf:type | schema:CreativeWork |
134 | sg:pub.10.1007/s00228-014-1787-6 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1024954211 |
135 | ″ | ″ | https://doi.org/10.1007/s00228-014-1787-6 |
136 | ″ | rdf:type | schema:CreativeWork |
137 | grid-institutes:grid.10025.36 | schema:alternateName | Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK |
138 | ″ | ″ | The Wolfson Centre for Personalised Medicine, University of Liverpool, Liverpool, UK |
139 | ″ | schema:name | Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK |
140 | ″ | ″ | The Wolfson Centre for Personalised Medicine, University of Liverpool, Liverpool, UK |
141 | ″ | rdf:type | schema:Organization |